These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 2295441
1. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum. Aalders JG, de Bruijn HW, Oosterhuis JW, Duk JM. Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441 [No Abstract] [Full Text] [Related]
2. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix. Lehtovirta P, Viinikka L, Ylikorkala O. Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974 [Abstract] [Full Text] [Related]
3. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics. Duk JM, De Bruijn HW, Groenier KH, Fleuren GJ, Aalders JG. Cancer; 1990 Apr 15; 65(8):1830-7. PubMed ID: 2317761 [Abstract] [Full Text] [Related]
4. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. Gadducci A, Ferdeghini M, Prontera C, Giordano P, Cristofani R, Bianchi R, Fioretti P. Eur J Gynaecol Oncol; 1990 Apr 15; 11(4):283-8. PubMed ID: 2245812 [Abstract] [Full Text] [Related]
5. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125. Verlooy H, Devos P, Janssens J, Mortelmans L, Gerits M, Bonte J, De Roo M. Gynecol Obstet Invest; 1991 Apr 15; 32(1):55-8. PubMed ID: 1765320 [Abstract] [Full Text] [Related]
6. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer. Picardo AL, Torres AJ, Maestro M, Ortega D, Garcia-Asenjo JA, Mugüerza JM, Hernando F, Diez M, Balibrea JL. Cancer; 1994 May 01; 73(9):2305-11. PubMed ID: 8168034 [Abstract] [Full Text] [Related]
7. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW. Obstet Gynecol; 1989 Apr 01; 73(4):661-8. PubMed ID: 2648225 [Abstract] [Full Text] [Related]
8. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung]. Moriya H, Suzuki S, Aizumi J, Kimura K, Urabe S, Higuci Y, Hoshi K. Rinsho Hoshasen; 1989 Jan 01; 34(1):63-6. PubMed ID: 2724610 [Abstract] [Full Text] [Related]
9. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC. Gynecol Oncol; 2000 Jan 01; 76(1):103-6. PubMed ID: 10620449 [Abstract] [Full Text] [Related]
10. Cervical carcinoma: a comparison of four potential biochemical tumor markers. Dodd JK, Henry RJ, Tyler JP, Houghton CR. Gynecol Oncol; 1989 Feb 01; 32(2):248-52. PubMed ID: 2910788 [Abstract] [Full Text] [Related]
11. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix. Gocze PM, Vahrson HW, Freeman DA. Oncology; 1994 Feb 01; 51(5):430-4. PubMed ID: 8052484 [Abstract] [Full Text] [Related]
12. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Senekjian EK, Young JM, Weiser PA, Spencer CE, Magic SE, Herbst AL. Am J Obstet Gynecol; 1987 Aug 01; 157(2):433-9. PubMed ID: 3475982 [Abstract] [Full Text] [Related]
13. Experiences with SCC antigen, a new tumor marker for cervical carcinoma. Meier W, Eiermann W, Stieber P, Schneider A, Fateh-Moghadam A, Hepp H. Eur J Cancer Clin Oncol; 1989 Nov 01; 25(11):1555-9. PubMed ID: 2591447 [Abstract] [Full Text] [Related]
14. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers. Lam CP, Yuan CC, Jeng FS, Tsai LC, Yeh SH, Ng HT. Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul 01; 50(1):7-13. PubMed ID: 1326391 [Abstract] [Full Text] [Related]
15. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus]. Gadducci A, Facchini V, Bartolini T, Fioretti P. Ann Ostet Ginecol Med Perinat; 1988 Jul 01; 109(3):151-5. PubMed ID: 3207319 [No Abstract] [Full Text] [Related]
16. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG. Tumour Biol; 1998 Jul 01; 19(6):505-16. PubMed ID: 9817980 [Abstract] [Full Text] [Related]
17. Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response. Leminen A, Alftan H, Stenman UH, Lehtovirta P. Acta Obstet Gynecol Scand; 1992 May 01; 71(4):293-7. PubMed ID: 1322623 [Abstract] [Full Text] [Related]
18. Cervical carcinoma antigen, carcinoembryonic antigen (CEA), and nonspecific cross-reacting antigen (NCA) in appraisal of uterine cervix smears. Harlozinska A, Kula J, Stepinska B, Jelen M, Richter R, Slesak B. Am J Clin Pathol; 1985 Mar 01; 83(3):301-7. PubMed ID: 3883744 [Abstract] [Full Text] [Related]
19. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri]. Ievleva ES, Ermoshina NV, Ageenko AI. Eksp Onkol; 1988 Mar 01; 10(5):33-5. PubMed ID: 3061778 [Abstract] [Full Text] [Related]